PHIO · Categories · Form 4

PHIO - SEC Form 4 insider transactions

Phio Pharmaceuticals Corp. (PHIO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PHIO

• 79d
  Director Lockshin Curtis was granted 16,600 shares, increasing direct ownership by 89% to 35,155 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 79d
  Director Freeman Jonathan E was granted 16,600 shares, increasing direct ownership by 103% to 32,655 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 79d
  Director Deming David H was granted 23,800 shares, increasing direct ownership by 170% to 37,800 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 79d
  Chief Financial Officer Carson Lisa Cabott was granted 47,000 shares, increasing direct ownership by 100% to 94,000 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 79d
  Director Bradford Patricia A was granted 18,500 shares, increasing direct ownership by 68% to 45,651 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 79d
  Chairman, Pres. & CEO Bitterman Robert J was granted 120,000 shares, increasing direct ownership by 41% to 411,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Amendment: Director Ferrara Robert L was granted 23,100 shares, increasing direct ownership by 147% to 38,766 units (SEC Form 4)

  4/A - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Director Deming David H was granted 14,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Director Lockshin Curtis was granted 16,200 shares, increasing direct ownership by 688% to 18,555 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Director Freeman Jonathan E was granted 14,700 shares, increasing direct ownership by 1,085% to 16,055 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Director Ferrara Robert L was granted 23,000 shares, increasing direct ownership by 147% to 38,666 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  VP, Finance and Administration Carson Lisa Cabott was granted 47,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Director Bradford Patricia A was granted 18,800 shares, increasing direct ownership by 225% to 27,151 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 223d
  Chairman, Pres. & CEO Bitterman Robert J covered exercise/tax liability with 4,111 shares and was granted 250,000 shares, increasing direct ownership by 963% to 271,421 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 590d
  VP, CFO Infarinato Robert M. was granted 3,000 shares, increasing direct ownership by 38% to 11,000 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 590d
  Director Freeman Jonathan E was granted 1,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 590d
  Chairman, Pres & CEO Bitterman Robert J was granted 15,500 shares, increasing direct ownership by 665% to 17,832 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 591d
  Director Lockshin Curtis was granted 2,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 591d
  Director Ferrara Robert L was granted 10,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 591d
  Director Bradford Patricia A was granted 8,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 619d
  VP, Chief Financial Officer Infarinato Robert M. was granted 8,000 shares (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 781d
  Kontulis Caitlin covered exercise/tax liability with 335 shares, decreasing direct ownership by 3% to 10,643 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 793d
  Bitterman Robert J covered exercise/tax liability with 1,804 shares, decreasing direct ownership by 10% to 16,490 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 795d
  Kontulis Caitlin covered exercise/tax liability with 1,181 shares, decreasing direct ownership by 10% to 10,978 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 935d
  Bitterman Robert J covered exercise/tax liability with 917 shares, decreasing direct ownership by 5% to 18,294 units (SEC Form 4)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1025d
  SEC Form 4 filed by Bitterman Robert J

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1046d
  SEC Form 4 filed by Ferrara Robert L

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Lockshin Curtis was granted 1,500 shares, increasing direct ownership by 88% to 3,197 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Freeman Jonathan E was granted 1,500 shares, increasing direct ownership by 88% to 3,197 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Ferrara Robert L was granted 1,500 shares, increasing direct ownership by 60% to 4,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Cauwenbergh Geert was granted 1,500 shares, increasing direct ownership by 55% to 4,235 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Bradford Patricia A was granted 1,500 shares, increasing direct ownership by 90% to 3,167 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Kontulis Caitlin was granted 4,500 shares, increasing direct ownership by 56% to 12,494 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1158d
  SEC Form 4: Bitterman Robert J was granted 11,000 shares, increasing direct ownership by 177% to 17,211 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1163d
  SEC Form 4: Kontulis Caitlin covered exercise/tax liability with 657 shares, decreasing direct ownership by 8% to 7,994 units to satisfy withholding tax

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1227d
  SEC Form 4: Bitterman Robert J bought $780 worth of shares (2,000 units at $0.39), increasing direct ownership by 3% to 74,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1234d
  SEC Form 4: Bitterman Robert J bought $780 worth of shares (2,000 units at $0.39), increasing direct ownership by 3% to 72,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1236d
  SEC Form 4: Bitterman Robert J bought $860 worth of shares (2,000 units at $0.43), increasing direct ownership by 3% to 70,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1237d
  SEC Form 4: Ferrara Robert L bought $2,041 worth of shares (5,000 units at $0.41), increasing direct ownership by 20% to 30,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1243d
  SEC Form 4: Bitterman Robert J bought $1,136 worth of shares (2,715 units at $0.42), increasing direct ownership by 4% to 68,541 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1244d
  SEC Form 4: Ferrara Robert L bought $820 worth of shares (2,000 units at $0.41), increasing direct ownership by 9% to 25,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1256d
  SEC Form 4: Bitterman Robert J bought $1,750 worth of Series D Preferred Stock (1 units at $1,750.00)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1300d
  SEC Form 4: Bitterman Robert J was granted 40,000 shares, increasing direct ownership by 155% to 65,826 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1307d
  SEC Form 4: Bradford Patricia A was granted 20,000 shares

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1514d
  SEC Form 4: Kontulis Caitlin covered exercise/tax liability with 4,011 shares, decreasing direct ownership by 4% to 103,815 units (withholding tax)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1514d
  SEC Form 4: Dispersyn Gerrit covered exercise/tax liability with 8,954 shares, decreasing direct ownership by 4% to 212,327 units (tax withholding)

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Lockshin Curtis was granted 10,000 shares, increasing direct ownership by 96% to 20,366 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Kontulis Caitlin was granted 68,000 shares, increasing direct ownership by 171% to 107,826 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Freeman Jonathan E was granted 10,000 shares, increasing direct ownership by 96% to 20,364 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Ferrara Robert L was granted 10,000 shares, increasing direct ownership by 77% to 23,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Dorman H. Paul was granted 10,000 shares, increasing direct ownership by 96% to 20,370 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Dispersyn Gerrit was granted 126,000 shares, increasing direct ownership by 132% to 221,281 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Cauwenbergh Geert was granted 10,000 shares, increasing direct ownership by 44% to 32,822 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1529d
  SEC Form 4: Bitterman Robert J was granted 10,000 shares, increasing direct ownership by 63% to 25,826 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1713d
  SEC Form 4: Dispersyn Gerrit bought $9,780 worth of Common stock (6,000 units at $1.63), increasing direct ownership by 7% to 95,281 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1878d
  SEC Form 4: Gerrit Dispersyn bought $5,000 worth of Common stock (1,953 units at $2.56), increasing direct ownership by 2% to 89,281 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1879d
  SEC Form 4: E Jonathan Freeman was granted 10,000 units of Common stock, increasing ownership by 2,747% to 10,364 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1879d
  SEC Form 4: Paul H. Dorman was granted 10,000 units of Common stock, increasing ownership by 2,703% to 10,370 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1879d
  SEC Form 4: Geert Cauwenbergh was granted 10,000 units of Common stock, increasing ownership by 78% to 22,822 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)
• 1879d
  SEC Form 4: L Robert Ferrara bought $2,148 worth of Common stock (682 units at $3.15) and was granted 10,000 units of Common stock, increasing ownership by 461% to 13,000 units

  4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

Other PHIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends